Recombinant Mouse CDC42 Protein，His

Cdc42, a member of the Rho family of small GTPases, plays a crucial role in regulating various cellular processes, including cell cycle progression, cytoskeletal dynamics, and cell signaling. As a molecular switch, Cdc42 oscillates between an active, GTP-bound state and an inactive, GDP-bound state, which is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Its dysregulation is implicated in several pathophysiological conditions, including cancer metastasis, where it promotes cell migration and invasion. The study of recombinant Cdc42 protein has provided valuable insights into its functional mechanisms and interactions with downstream effectors, such as PAK proteins and WASP, which are critical in actin polymerization and formation of cellular structures. Recombinant Cdc42 is typically produced in bacterial expression systems, allowing researchers to obtain large quantities of the protein for biochemical and structural studies. This research is pivotal for understanding Cdc42's role in normal physiology and disease states, potentially unveiling novel therapeutic targets for cancer and other disorders linked to Cdc42 malfunction. With advancements in protein engineering and assay development, studies employing recombinant Cdc42 are enhancing our comprehension of its mechanisms of action, providing foundational knowledge for future drug design and therapeutic interventions targeting Cdc42-related pathways.